68P Real-world outcomes of nivolumab and/or ipilimumab in patients with stage III-IV melanoma, MELIOR study by Rivas, A. Soria, Berciano Guerrero, M.A., Muñoz-Couselo, E., Cerezuela-Fuentes, P.C., Aguado, C., Ayala de Miguel, P., Herrero, G. Crespo, Sanz, L. Gutierrez, Garcia, L. Ostios, Larena, D. Vilanova, Algarra, S. Martin, Marquez-Rodas, I.

Get full text